Autism Spectrum Disorders in Developing Countries: Lessons from the Arab World

Abstract

The majority of research in the field of autism has been conducted in Western countries with readily available resources. In the developing countries and specifically in the Arab world, the field of child psychiatry is relatively new. Autism was not the subject of interest in the region until the late 1990s. Lack of awareness and culture as well as lack of resources contribute to the unmet needs of autism patients in the region. Tremendous effort is needed to raise the awareness of policy makers towards the need for implementation of services and research plans aiming to bridge the gap between needs and services. This chapter reviews the condition of autism in the developing Middle East Arab countries with special highlights on the prevalence and clinical status of autism. Also, lights will be shed on economic status, care provision, and research status of particular relevance to this developing Arab world.

Keywords

Mercury Cadmium Glutathione Arsenic Cortisol 

References

  1. Abu-Amero KK, Hellani AM, Salih MA, et al. A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation. BMC Med Genet. 2010;11:135. http://www.biomedcentral.com/1471–2350/11/135. Accessed 20 Jan 2012.
  2. Abu-Dahab SM, Skidmore ER, Holm MB, et al. Motor and tactile-perceptual skill differences between individuals with high-functioning autism and typically developing individuals ages 5–21. J Autism Dev Disord. 2012. http://www.springerlink.com/content/r5t7331p48511662/. Accessed 15 Jan 2012.
  3. Al-Ayadhi LY. Relationship between sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochem Res. 2012;37:394–400.PubMedCrossRefGoogle Scholar
  4. Al-Ayadhi LY, Mostafa GA. Low plasma progranulin levels in children with autism. J Neuroinflammation. 2011a;8:111.PubMedCrossRefGoogle Scholar
  5. Al-Ayadhi LY, Mostafa GA. Increased serum osteopontin levels in autistic children: relation to the disease severity. Brain Behav Immun. 2011b;25:1393–8.PubMedCrossRefGoogle Scholar
  6. Al-Farsi YM, Al-Sharbati MM, Al-Farsi OA, et al. Brief report: prevalence of autistic spectrum disorders in the Sultanate of Oman. J Autism Dev Disord. 2011;41:821–5.PubMedCrossRefGoogle Scholar
  7. Al-Gadani Y, El-Ansary A, Attas O, et al. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42:1032–40.PubMedCrossRefGoogle Scholar
  8. AL-Othman, I. (2010, March 20). Autism. Retrieved August 15, 2010, from http://www.youtube.com/watch?v=-ZfmvHlEEwQ
  9. Almasoud H. Services and support for individuals with autism: a comparative study between the UK and Saudi Arabia. 2010. http://faculty.ksu.edu.sa/almasoud/DocLib/Services%20and%20support%20for%20autistic%20people%D8%A3.%20%D8%AD%D9%86%D8%A7%D9%86%20%D8%B9%D9%84%D9%8A%20%D8%A7%D9%84%D9%85%D8%B3%D8%B9%D9%88%D8%AF.pdf. Accessed 20 Feb. 2012.
  10. Al-Qabandi M, Gorter JW, Rosenbaum P. Early autism detection: are we ready for routine screening? Pediatrics. 2011;128:211–7.CrossRefGoogle Scholar
  11. Al-Salehi SM, Ghaziuddin M. G6PD Deficiency in autism: a case-series from Saudi Arabia. Eur Child Adolesc Psychiatry. 2009;18:227–30.PubMedCrossRefGoogle Scholar
  12. Al-Salehi SM, Al-Hifthy EH, Ghaziuddin M. Autism in Saudi Arabia: presentation, clinical correlates and comorbidity. Transcult Psychiatry. 2009;46:340–7.PubMedCrossRefGoogle Scholar
  13. Al-Yafee YA, Al-Ayadhi LY, Haq SH, et al. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. BMC Neurol. 2011;11:139. http://www.biomedcentral.com/1471–2377/11/139. Accessed 2 Jan 2012.
  14. Amr M, Raddad D, El-Mehesh F, et al. Sex differences in Arab children with autism spectrum disorders. J Res Autism Spect Disord. 2011;5:1343–50.CrossRefGoogle Scholar
  15. Bastaki LA, Hegazy F, Al-Heneidi MM, et al. Fragile X syndrome: a clinico-genetic study of mentally retarded patients in Kuwait. East Mediterr Health J. 2004;10:116–24.PubMedGoogle Scholar
  16. Bayou N, M’rad R, Belhaj A, et al. The creatine transporter gene paralogous at 16p11.2 is expressed in human brain. Comparat Funct Gen. 2008. http://www.hindawi.com/journals/cfg/2008/609684/. Accessed 18 Jan 2012.
  17. Bayou N, Belhadj A, Daoud H, et al. Exploring the 7p22.1 chromosome as a candidate region for autism. J Biomed Biotech. 2010. http://www.hindawi.com/journals/jbb/2010/423894/. Accessed 15 Feb 2012.
  18. Croen L, Najjar D, Ra T, et al. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006;118:e1203–11.PubMedCrossRefGoogle Scholar
  19. Daley TC. The need for cross-cultural research on the pervasive developmental disorders. Transcult Psychiatry. 2002;39:531–50.Google Scholar
  20. Eapen V, Mabrouk AA, Zoubeidi T, et al. Prevalence of pervasive developmental disorders in preschool children in the UAE. J Trop Pediatr. 2007;53:202–5.PubMedCrossRefGoogle Scholar
  21. El-Ansary AK, Bacha AB, Ayadhi LY. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis. 2011a;10:63. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107801/?tool=pubmed. Accessed 5 Jan 2012.
  22. El-Ansary AK, Bacha AG, Al-Ayadhi LY. Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia. Clin Biochem. 2011b;44:1116–20.PubMedCrossRefGoogle Scholar
  23. El-Ansary AK, Ben Bacha AG, Al-Ayadhi LY. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia. J Neuroinflammation. 2011c;8:142. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213048/?tool=pubmed. Accessed 20 Jan 2012.
  24. El-Baz F, Ismael NA, Nour Eldin SM. Risk factors for autism: an Egyptian study. Egyptian J Med Human Genet. 2011;12:31–8.CrossRefGoogle Scholar
  25. Essa MM, Guillemin GJ, Waly MI. Increased markers of oxidative stress in autistic children of the Sultanate of Oman. Biol Trace Elem Res. 2011. http://www.ncbi.nlm.nih.gov/pubmed/22127832. Accessed 15 Jan 2012.
  26. Fido A, Al-Saad S. Toxic trace elements in the hair of children with autism. Autism. 2005;9:290–8.PubMedCrossRefGoogle Scholar
  27. Fido A, Al-Saad S. Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Kuwait. Med Princ Pract. 2008;17:415–8.PubMedCrossRefGoogle Scholar
  28. Fillano JJ, Goldenthal MJ, Rhodes CH, et al. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol. 2002;17:435–9.PubMedCrossRefGoogle Scholar
  29. Gebril OH, Meguid NA. HFE gene polymorphisms and the risk for autism in Egyptian children and impact on the effect of oxidative stress. Dis Markers. 2011;31:289–94.PubMedCrossRefGoogle Scholar
  30. Hamza RT, Hewedi DH, Ismail MA. Basal and adrenocorticotropic hormone stimulated plasma cortisol levels among Egyptian autistic children: relation to disease severity. Ital J Pediatr. 2010;36:71. http://www.ijponline.net/content/36/1/71. Accessed 3 Feb 2012.Google Scholar
  31. Hussein H, Taha GRA, Almanasef A. Characteristics of autism spectrum disorders in a sample of Egyptian and Saudi patients: transcultural cross sectional study. Child Adolesc Psychiatr Ment Health. 2011;5:34. http://www.capmh.com/content/5/1/34. Accessed 2 Jan 2012.
  32. Hussein H, Shaker N, Elsheikh M, Ramy HA. Pathways to child mental health services among patients in an urban clinical setting in Egypt, Pychiatric Services. 2012;63(12):1225–30.Google Scholar
  33. Japan International Cooperation Agency Planning and Evaluation Department. Country profile on disability. Arab republic of Egypt. 2002. http://siteresources.worldbank.org/DISABILITY/Resources/Regions/MENA/JICA_Egypt.pdf. Accessed 20 Mar 2012.
  34. Järbrink K. The economic consequences of autistic spectrum disorder among children in a Swedish municipality. Autism. 2007;11:453–63.PubMedCrossRefGoogle Scholar
  35. Järbrink K, Knapp M. The economic impact of autism in Britain. Autism. 2001;5:7–22.PubMedCrossRefGoogle Scholar
  36. Kawashti MI, Amin OR, Rowehy NG. Possible immunological disorders in autism: concomitant autoimmunity and immune tolerance. Egypt J Immunol. 2006;13:99–104.PubMedGoogle Scholar
  37. Kaya N, Colak D, Albakheet A, et al. A novel X-linked disorder with developmental delay and autistic features. Ann Neurol. 2012;71:498–508.PubMedCrossRefGoogle Scholar
  38. Kheir N, Ghoneim OL, Sandridge A, et al. Quality of life of caregivers of children with autism in Qatar. Autism. 2012;16:293–8.PubMedCrossRefGoogle Scholar
  39. Masri AA, Hamamy HH, Khreisat AA. Profile of developmental delay in children under five years of age in a highly consanguineous community: a hospital-based study-Jordan. Brain Develop. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21194858. Accessed 3 Feb 2012.
  40. Meguid NA, Atta HM, Gouda AS, et al. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. Clin Biochem. 2008;41:1044–8.PubMedCrossRefGoogle Scholar
  41. Meguid N, Fahim C, Yoon U. Brain morphology in autism and fragile x syndrome correlates with social IQ: first report from the Canadian-Swiss-Egyptian neurodevelopmental study. J Child Neurol. 2010a;25:599–608.PubMedCrossRefGoogle Scholar
  42. Meguid NA, Hashish AF, Anwar M, et al. Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J Altern Complement Med. 2010b;6:641–5.CrossRefGoogle Scholar
  43. Meguid NA, Dardir AA, Abdel-Raouf ER, et al. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res. 2011;143:58–65.PubMedCrossRefGoogle Scholar
  44. Mendoza RL. The economics of autism in Egypt. Am J Econ Bus Admin. 2010;2:12–9.CrossRefGoogle Scholar
  45. Mostafa A. The medical community in the Middle East needs to redouble its efforts to ensure early diagnosis and the best intervention in children with autism (commentary). Middle East. 2011.147. http://www.nature.com/nmiddleeast/2011/012345/full/nmiddleeast.2011.147.html. Accessed 20 Jan 2012.
  46. Mostafa GA, Al-Ayadhi LY. The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. J Neuroinflammation. 2011a;8:180. http://www.jneuroinflammation.com/content/8/1/180. Accessed 20 Jan 2012.
  47. Mostafa GA, Al-Ayadhi LY. Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. J Neuroinflammation. 2011b;8:39. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104945/?tool=pubmed. Accessed 20 Jan 2012.
  48. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation. 2011c;8:71. http://www.jneuroinflammation.com/content/8/1/71. Accessed 15 Jan 2012.
  49. Mostafa GA, Al-Ayadhi LY. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur J Paediatr Neurol. 2012. http://www.ncbi.nlm.nih.gov/pubmed/22226851. Accessed 23 Feb 2012.
  50. Mostafa GA, Kitchener N. Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr Neurol. 2009;40:107–12.PubMedCrossRefGoogle Scholar
  51. Mostafa GA, Shehab AA. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol. 2010;223:115–9.PubMedCrossRefGoogle Scholar
  52. Mostafa GA, El-Sayed ZA, El-Aziz MM, et al. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J Child Neurol. 2008;23:1413–8.PubMedCrossRefGoogle Scholar
  53. Mostafa GA, Al Shehab A, Fouad NR. Frequency of CD4+CD25 high regulatory T cells in the peripheral blood of Egyptian children with autism. J Child Neurol. 2010a;25:328–35.PubMedCrossRefGoogle Scholar
  54. Mostafa GA, El-Hadidi ES, Hewedi DH, et al. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol. 2010b;26:114–8.CrossRefGoogle Scholar
  55. Neergaard L. Genes from Middle East families yield autism clues. Harvard Medical School, Genetics. AP. 2008. http://abcnews.go.com/Health/Autism/story?id=5349700&page=1#.T7AqpOh7ppA. Accessed 15 Jan 2012.
  56. Nilofernaqui M. Prevalence and services in countries outside of Europe and North America. 2012. http://www.hunter.cuny.edu/school-of-education/special-programs-andcenters/regional-autism-center/repository/files/NNaquviprevalenceoutsideUS.pdf. Accessed 5 Feb 2012.
  57. Okasha A. Mental health services in the Arab world. Arab Studies Quarterly (ASQ). 2003. http://www.questia.com/googleScholar.qst?docId=5006442637. Accessed Jan 2012.
  58. Omar AO, Ahmad AE, El Bashir H, et al. Trisomy 13 in a 7-year-old girl with cerebellar tumor, eye abnormalities, and autistic features. Am J Med Genet A. 2009;149:1056–7.CrossRefGoogle Scholar
  59. Oriel KN, George CL, Peckus R, et al. The effects of aerobic exercise on academic engagement in young children with autism spectrum disorder. Pediatr Phys Ther. 2011;23:187–93.PubMedCrossRefGoogle Scholar
  60. Ouldim K, Natiq A, Jonveaux P, et al. Tetrasomy 15q11–q13 diagnosed by fish in a patient with autistic disorder. J Biomed Biotechnol. 2007. http://www.hindawi.com/journals/jbb/2007/061538/abs/. Accessed 15 Jan 2012.
  61. Samadi SA, McConkey R. Autism in developing countries: Lessons from Iran. Autism Res Treat. 2011. http://www.hindawi.com/journals/aurt/2011/145359/. Accessed 23 Mar 2012.
  62. Seif Eldin A, Habib D, Noufal A, et al. Use of M-CHAT for a multinational screening of young children with autism in the Arab countries. Int Rev Psychiatry. 2008;20:281–9.PubMedCrossRefGoogle Scholar
  63. Sharpe DL, Baker DL. The financial side of autism: private and public costs. In: Mohammad-Reza M, editor. A comprehensive book on autism spectrum disorders. InTech; 2011. pp. 275–296. http://www.intechopen.com/books/a-comprehensive-book-on-autism-spectrum-disorders. Accessed 20 Feb 2012.
  64. Taha GRA, Hussein H, Almanasef A. Two years outcome of autism in a sample of Egyptian and Saudi children: a comparative prospective naturalistic study will be published in Middle East Current Psychiatry, July 2013 issue (page no is not yet known).Google Scholar
  65. United Nations Statistics Division. Demographic year book. 2008. http://unstats.un.org/unsd/demographic/products/dyb/dyb2008.htm. Accessed 28 Mar 2012.
  66. Van Dyke EM. Autistic disorder: early interventions can improve outcomes. J Am Acad Physic Assist. 2007;22:18–20. http://www.jaapa.com/autistic-disorder-earlyinterventions-can-improveoutcomes/article/139806/. Accessed 15 Jan 2012.Google Scholar
  67. WHO. Overview of child health in Arab countries: EMRO’s contribution to the report for the high level Arab conference in preparation for the Arab participation in the UN General Assembly special session on children. 2001. http://www.emro.who.int/cah/pdf/childhealth-arabcountries.pdf. Accessed 20 Mar 2012.
  68. Xiong N, Yang L, Yu Y, et al. Investigation of raising burden of children with autism, physical disability and mental disability in China. Res Develop Dis. 2011;32:306–11.CrossRefGoogle Scholar
  69. Yazbak FE. Autism seems to be increasing worldwide, if not in London. Br Med J. 2004;328:226–7.CrossRefGoogle Scholar
  70. Zeglam AM, Maouna A. Is there a need for a focused health care service for children with autistic spectrum disorders? A keyhole look at this problem in Tripoli, Libya. Autism. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21920990. Accessed 3 Mar 2012.

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Institute of Psychiatry (WHO Collaborating Center for Training and Research), Department of NeuropsychiatryAin Shams UniversityCairoEgypt

Personalised recommendations